The results indicated that PXDN mainly regulates GBM development by activating cancer hallmarks, including fatty acid metabolism, epithelial-mesenchymal transition, inflammatory response, glycolysis, hypoxia and Wnt/beta-catenin signaling pathway. The gene discussed is PXDN; the disease is cancer.